In vivo in the rat 1,25(OH)2D3 decreases and a low calcium increases PTH mRNA levels. We now report the effect of 3 and 8 wk of changes in dietary vitamin D and calcium on PTH mRNA levels. PTH mRNA levels were increased by 3 wk of calcium deficiency (five times), a vitamin D-deficient diet (two times), and combined deficiency (10 times), but not changed by high calcium. Vitamin D-deficient-diet rats' PTH mRNA did not decrease after a single large dose of 1,25(OH)2D3, but did decrease partially after repeated daily doses of 1,25(OH)2D3. Rats after a vitamin D-, calcium-deficient (-D-Ca) diet did not respond to changes in serum calcium at 1 h. Flow cytometry of isolated cells from parathyroid-thyroid tissue separated the smaller parathyroid from the larger thyroid cells and allowed an analysis of parathyroid cell number. In normal vitamin D/normal calcium (NDNCa) rats the parathyroid cells were 24.7±3.4% (n = 6) of the total cell number, whereas in -D-Ca rats they were 41.8±6.6% (n = 6) (P < 0.05). That is, -D-Ca rats had 1.7 times the number of cells, whereas they had 10 times the amount of PTH mRNA, indicating the major contribution (6 times) of increased PTH gene expression per cell. Moreover, a calcium-deficient, more so than a vitamin D-deficient diet, amplifies the expression of the PTH gene, and vitamin D is necessary for an intact response of PTH mRNA to 1,25(OH)2D3 or calcium. (J. Clin. Invest. 1990Invest. . 86:1313Invest. -1319
Introduction
The hormones PTH, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3)' and calcitonin are the major calciotrophic hormones. Calcium not only determines PTH secretion but also regulates PTH gene expression both in vitro (1, 2) and in vivo (3, 4) . Calcitonin, on the other hand, is secreted in response to a high calcium but its transcription is not affected by calcium (4) . The transcription of both PTH and calcitonin genes is markedly reduced by 1,25(OH)2D3 both in vitro (5) (6) (7) and in vivo (8, 9) , suggesting a central role for 1,25(OH)2D3 in orchestrating calcium homeostasis.
The regulation of PTH gene transcription is relevant not only in understanding the physiology ofthe parathyroid gland, but also in the pathophysiology of diseases involving the parathyroid where there is parathyroid hyperplasia. Secondary parathyroid hyperplasia is a complication of chronic renal disease or vitamin D deficiency, and may lead to disabling skeletal complications. We have therefore studied the regulation of PTH gene expression in parathyroid hyperplasia in rats due to dietary deficiencies ofcalcium and/or vitamin D, as well as the effect ofa high dietary calcium causing chronic hypercalcemia. We have demonstrated in vivo in the rat that PTH mRNA levels are not affected by a high calcium, but are increased by a vitamin D-deficient diet and even more so by a calcium deficient diet. Vitamin D-deficient rats did not respond normally to single doses of 1,25(OH)2D3 or acute changes in serum calcium.
The relative contribution of increased transcription per parathyroid cell to increased cell number was studied.
Methods
Animals. Weanling male Hebrew University strain rats (30 g) were maintained in an UV light-free environment for 3 (-D+Ca) (TD 89155) . Some rats were then treated intraperitoneally with 1,25(OH)2D3, calcium gluconate, or calcitonin (4). The thyroids with attached parathyroids were excised under pentobarbital anesthesia and blood samples were taken. The excised tissue was immediately frozen in liquid nitrogen and stored at -70°C until extraction. There were four rats in all groups studied but there were only three rats in the groups fed vitamin D-deficient diets (-D) for 8 wk, because one rat died (-D+Ca), and serum was pooled from 2 rats of -D-Ca and -DNCa.
Measurement of cellular mRNA levels. Total RNA was prepared from thyroid-parathyroid by homogenization in guanidium thiocyanate as previously described (8) . Dot blots of total tissue RNA extracts were prepared by formaldehyde denaturation followed by serial dilutions with 15X SSC. The diluted samples were spotted on a nitrocellulose filter (0.45 gm; Schleicher & Schuell, Keene, NH) soaked in lOX SSC, using a manifold apparatus. For Northern blots, RNA and markers were denatured and size-fractionated by electrophoresis on 1.5% agarose gels containing formaldehyde and transferred to nitrocellulose filters by diffusion blotting. The filters were baked at 80°C for 120 min in a vacuum oven. Dot blots and Northern blots were hybridized to rat preproPTHcDNA in plasmid PT43, using a nick-translated gel-purified restriction fragment (2-5 X 108 cpm/.ug) as before (8) .
Serum calcium was measured in a Roche autoanalyzer. Serum 1,25(OH)2D3 levels were measured by a radioreceptor assay after chromatography on HPLC.
Flow cytometry ofthyroparathyroid cells (10) . For sample preparation, thyroparathyroid tissue from normal rats (NDNCa) and -D-Ca rats was placed in BME medium with 5% FCS at 4°C, minced and then incubated with collagenase (500 U/ml) (Worthington Biomedicals, Malvern, PA) at 37°C for 1 h in a shaking water bath. There was complete digestion of the glands to isolated cells. The cell suspension was filtered through a nylon mesh, then centrifuged at 400 g for 5 min at 4°C, washed twice in Hanks buffer and the pellet resuspended in 500 id of Hanks' buffer.
Fluorescent staining with 3',6'-diacetylfluorescein (FDA) and propidium iodide. Diacetyl fluorescein (Sigma Chemical Co., St. Louis, MO) dissolved in acetone (5 mg/ml) was stored at -20°C. Immediately before analysis 1 ,aI FDA was added to 100 AL of parathyroid-thyroid cell suspension (1 1, 12) . To other dilute cell suspensions propidium iodide (50 ug/ml) was added at 1 td to 100 jil of cell suspension (10) .
Measurement procedure. The samples were analyzed by a FACS 440 cell sorter (Becton-Dickinson Co., Malvern, PA) using 300 mV excitation at 488 nm from an argon ion laser source. The diameter of the nozzle used was 70 ,um. The fluorescent angle light scatter was at 520 nm ( 11) .
Statistics were analyzed by t test.
Results
After 3 wk of the diets serum 1,25(OH)2D3 levels were not significantly different: for control rats (NDNCa), the levels were 154±20 pg/ml (n = 3), for ND+Ca rats, the levels were 167±6 pg/ml (n = 3), and for -DNCa rats, the levels were 124±12 pg/ml (n = 4). However, ND-Ca rats had higher levels: 858±61 pg/ml (n = 3), P < 0.01, compared to NDNCa, and -D-Ca rats had lower levels: 90.7±13 pg/ml (n = 3), P < 0.05 compared with NDNCa.
After 3 wk of the diets given to weanling rats, serum calcium and PTH mRNA were strikingly different amongst the groups (Fig. 1) , whereas actin mRNA levels were the same in all the groups (not shown). The (Fig. 2) . After 8 wk of the diets given to weanling rats PTH mRNA levels were increased in rats with the calcium-deficient diets (ND-Ca, -D-Ca) but not in rats with vitamin D-deficient diets (-DNCa; -D+Ca) ( Table I) . A high calcium diet (ND+Ca, -D+Ca) for 8 wk had no effect on PTH mRNA levels (Table I) .
Further studies were performed on rats after 3 wk on the diets. We had previously shown that when 1,25(OH)2D3 was injected intraperitoneally to normal rats (NDNCa) there was a marked reduction in PTH mRNA levels with as little as 12.5 pmol of 1,25(OH)2D3 (results from reference 8 reproduced in Fig. 3 ). In contrast, after a vitamin D-deficient diet rats (-D-Ca and -DNCa at 3 wk) showed no response to single doses of 1,25(OH)2D3 as high as 1 nmol (Fig. 3) . When the -D-Ca and -DNCa were given repeated doses of 1,25(OH)2D3 (O00 pmol) for 3 or 5 d, there was a reduction in PTH mRNA levels that was only significant in the -DNCa (P < 0.05) (Fig. 4) . In NDNCa rats, at 1 h after small reductions in serum calcium there were large increases in PTH mRNA levels (4), so we examined the response at 1 h to changes in serum calcium. ND-Ca rats increased their PTH mRNA levels when their serum calciums were reduced by administration ofintraperitoneal calcitonin (Fig. 5) . On the other hand, -D-Ca rats' PTH mRNAs were not altered when serum calcium was decreased to 3.0 mg/dl or increased to 12 mg/dl (Fig. 5) . At a serum calcium of2.0 mg/dl there was a large decrease in PTH mRNA in -D-Ca rats, and at a longer time interval (3 h) with an excessive serum calcium (24 mg/dl), there was a decrease (10 OD units) (data not shown). In our previous work, when NDNCa rats were injected with calcium, the serum calcium increased from 11 to 25 mg/dl at 1 h but there was no change in PTH mRNA levels (4).
Flow cytometry studies Identification of cell populations. A mixed cell suspension from thyroparathyroid tissue when separated on the flow cytometer by size demonstrated at least two populations of cells. There was an initial peak of smaller cells (0-100 nm) and a later peak (101-254 nm) of larger cells (Fig. 6 ). The cells from the two peaks were separated by a cell sorter and then analyzed for mRNA content. The smaller cells contained only PTH mRNA and not thyroglobulin mRNA, whereas the second peak of larger cells hybridized with the thyroglobulin cDNA and not with the PTHc DNA (Fig. 6) , demonstrating that the parathyroid and thyroid cells were clearly separated by the flow cytometer. This method was then used to determine the number ofcells in each peak in control rats (NDNCa) and rats with the highest PTH mRNA levels (-D-Ca). To (14) . It is not clear why the PTH mRNA levels were increased in -DNCa rats at 3 wk, but not in rats on the same diet at 8 wk, an issue which warrants further study. In the present study, the -D-Ca rats were lighter at 3 wk, and had lower serum 1,25(OH)2D levels, whereas the -DNCa rats were not lighter and had normal serum calciums. The mechanism whereby the -DNCa rats had higher PTH mRNA levels despite normal serum 1,25(OH)2D is not clear but might possibly represent a lower total body vitamin D content, decrease in other vitamin D metabolites that might affect the 1,25(OH)2D3 receptor, or possibly changes in free 1,25(OH)2D levels rather than total 1,25(OH)2D levels which were measured in this study.
The -D-Ca group with the largest increase in PTH mRNA levels not only had low serum calciums but also were the only group to have low serum 1,25(OH)2D levels. Both of these factors could be responsible for the striking changes in PTH mRNA in this group. They also had the lowest body weights (mean of 100 g, NDNCa = 175 g) and since pair feeding was not performed, it is not possible to eliminate the possibility that starvation or malnutrition contributed to the results in this group. The very high serum 1,25(OH)2D levels in rats on ND-Ca is well known ( 15) . What is of interest is that despite the high serum 1,25(OH)2D levels the PTH mRNA levels were fivefold those of ND NCa which indicates the dominant effect of low calcium whether it be on transcription or on replication or both. In acute studies, we had showed that the effect of 1,25(OH)2D in decreasing PTH mRNA levels was dominant over the effect of a low calcium in increasing PTH mRNA, but this seems not to be the case in long-term studies (4). Moreover, ND-Ca rats responded to acute hypocalcemia by increasing their PTH mRNA, suggesting an intact response (Fig.  5) . However, they did not decrease their PTH mRNA after increasing the serum calcium to normal or very high levels at 1 h. Studies at longer times were not performed.
The results of these in vivo chronic studies supplement those of our earlier acute studies and together allow a clearer understanding of the regulation of PTH gene expression in vivo. A high calcium diet that led to a high serum calcium at 3 wk did not decrease PTH mRNA levels. This is in agreement with our short-term studies up to 6 h (4). Wernerson (17) found that vitamin D-deficient dogs also had a twofold increase in PTH mRNA levels. The moderately increased PTH mRNA of vitamin D deficiency might be a result of increased transcription per cell, because 1,25(OH)2D3's action on the PTH gene is to dramatically decrease transcription (8) as well as parathyroid cell hyperplasia, because both in vitro (13) and in chronic renal failure rats (14) 1,25(OH)2D3 inhibited parathyroid cell proliferation. The effect of a low calcium in the present study was to dramatically increase PTH mRNA levels, in rats who had been fed both vitamin D-replete and -deplete diets. This is in agreement with our in vivo studies at 1-6 h, and Yamamoto's studies at 48 h (3). The increased PTH mRNA as a result of a low calcium may be a combination of increased transcription per cell, cell hypertrophy (19) , and increased cell number. Hypocalcemia is certainly the major stimulator of increased PTH mRNA levels, rather than a vitamin D-deficient diet. (Fig. 5) . In contrast -D-Ca rats did not respond to changes in their serum calcium at 1 h from 3 to 12 mg/dl. When the serum calcium was reduced to the unphysiologic level of2 mg/dl there was a large reduction in PTH mRNA but still twice that of controls (Fig. 5) . In vitro, at very low extracellular calcium PTH secretion is completely turned off (21) . Therefore, some extracellular calcium is needed for the para-thyroid cell to function normally. These results suggest, at least, that vitamin D is necessary for parathyroid glands' PTH mRNA levels to respond to acute changes in serum calcium.
It was important to determine whether the increase in PTH mRNA after the different diets was due to increased transcription per cell or to an increase in the number of parathyroid cells. One possible methodology was the use of in situ hybridization, but the sensitivity of this method is limited. We therefore elected to determine the number of parathyroid cells by producing a cell suspension from the thyro-parathyroid tissue, and then analyzing and characterizing the cells using a flow cytometer. Fortunately, there was a clear separation by size of the larger thyroid cells from the smaller parathyroid cells. The first peak, containing the parathyroid cells, would also contain cell debris but we demonstrated by the use of fluorescein diacetate (FDA) that we were dealing with viable cells. FDA is uncharged and lipid soluble and readily crosses cell membranes (11, 12) . Once inside the cell, ester molecules are readily and rapidly hydrolyzed to free fluorescein by nonspecific esterases, which are present in almost all cells. The ester is not fluorescent, whereas the free fluorescein anion, which is retained by intact cells, renders them highly fluorescent (12) . By this criterion 80% of the cells were viable with membrane integrity.
Comparison of NDNCa rats to -D-Ca rats showed that -D-Ca rats had 1.7-fold the number of parathyroid cells compared with NDNCa rats. The PTH mRNA in the -D-Ca rats was 10-fold higher than the NDNCa rats. Therefore the increased PTH gene expression per parathyroid cell accounted for most of the increase in PTH mRNA (6-fold), whilst increased cell number accounted for much less (1.7-fold). This methodology lends itselfto further studies on the regulation of parathyroid cell replication.
These in vivo studies therefore indicate that after long-term dietary changes PTH mRNA levels were not affected by a high calcium, were increased by a vitamin D-deficient diet and even more so by calcium deficiency. Rats that had been on a vitamin D-deficient diet for 3 wk did not respond normally to acute stimuli of 1,25(OH)2D3 or changes in serum calcium. The results of these studies are relevant to our understanding of the pathophysiology of parathyroid hyperplasia in human vitamin D deficiency and chronic renal failure.
In chronic renal failure patients, severe secondary hyperparathyroidism develops as a consequence of low 1,25(OH)2D3 levels (22) and a low serum calcium. Early treatment with 1,25(OH)2D3 and calcium prevents the hyperparathyroidism and the bone disease (23) (24) (25) , however established secondary hyperparathyroidism is very resistant to therapy. In both human and experimental chronic renal failure a decreased number of parathyroid 1,25(OH)2D3 receptors has been demonstrated (26) (27) (28) , and immunoreactive PTH levels have been shown to decrease after large, repeated doses of 1,25(OH)2D3, and only minimally to increases in serum calcium (29) . Those findings are similar to the results of the present study using a dietary model of secondary hyperparathyroidism where PTH mRNA levels decreased after repeated 1,25(OH)2D3 doses but not to increases in serum calcium.
